David Cunningham
Royal Marsden NHS Foundation Trust
13
12
10
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+7 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (13)
Showing 10 of 13 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Paul Fields
Guy's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Nebojsa Andjelkovic
Clinical Center Kragujevac
Shared therapeutic areas:
Worked with same sponsors:
Giulino Roth
Weill Cornell Medicine New York
Shared therapeutic areas:
Worked with same sponsors:
Graham Collins
Churchill Hospital
Shared therapeutic areas:
Worked with same sponsors:
Sinisa Radulovic
Institute for Oncology and Radiology Serbia
Shared therapeutic areas:
Worked with same sponsors:
Sabrina Kurtovic
University Clinical Center, Sarajevo
Shared therapeutic areas:
Worked with same sponsors:
Netanel Horowitz
University of Haifa
Shared therapeutic areas:
Worked with same sponsors:
Ivan Tijanic
Clinical Center Nis
Shared therapeutic areas:
Worked with same sponsors:
Rakesh Popat
Univeristy College London
Shared therapeutic areas:
Worked with same sponsors:
Carole Soussain
Curie Institute
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (13)
Showing 13 of 13 trials
Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer
Open-Label, Non Randomized Phase 2 Study With Safety Run-In
A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours
Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer
Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma
Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer
Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus
Molecular Markers of Prognosis in Colorectal Cancer Patients
Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer
Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours
R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma
Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal Cancer
Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic Cancer
All 13 trials loaded